Rhythm Biosciences (ASX:RHY) EV-to-EBITDA : -2.49 (As of May. 03, 2024)

Rhythm Biosciences EV-to-EBITDA Chart

Rhythm Biosciences Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial								-	-21.43	-	-7.58	-

Competitive Comparison of Rhythm Biosciences's EV-to-EBITDA

For the Diagnostics & Research subindustry, Rhythm Biosciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhythm Biosciences's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rhythm Biosciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Rhythm Biosciences's EV-to-EBITDA falls into.

Rhythm Biosciences EV-to-EBITDA Calculation

Rhythm Biosciences's EV-to-EBITDA for today is calculated as:

Rhythm Biosciences's current Enterprise Value is A$18.95 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Rhythm Biosciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-7.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhythm Biosciences  (ASX:RHY) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Rhythm Biosciences's PE Ratio for today is calculated as:

Rhythm Biosciences's share price for today is A$0.082.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Rhythm Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.038.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Rhythm Biosciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Biosciences (ASX:RHY) Business Description